WELL Health Technologies Corp.

WELL Health Technologies Corp.

WHTCF
WELL Health Technologies Corp.US flagOther OTC
3.52
USD
+0.20
- -
899.24MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
0.03
- -
- -
0.34
0.38
1.58
2.58
3.28
3.73
5.54
4.37
Basic EPS, GAAP
-0.02
-0.01
-0.02
-0.06
-0.24
- -
-0.08
-0.03
-0.23
0.01
- -
0.13
-0.03
0.09
Free Cash Flow per Basic Share
-0.02
- -
-0.01
-0.05
-0.04
- -
-0.03
-0.05
0.1
0.32
0.25
-0.03
0.37
0.25
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.09
0.07
0.04
0.04
-0.03
- -
0.29
1.58
2.98
2.91
2.91
3.06
3.04
3.01
Tangible Book Value per Share
0.1
0.08
0.05
-0.02
-0.03
- -
0.07
0.63
-1.78
-1.16
-0.92
-0.85
-2.01
-2.18
Basic Weighted Avg Shares
5
7
7
10
23
- -
97
134
191
221
237
247
253
254
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
6
33
50
302
569
776
920
1,400
1,110
Operating Margin (%)
- -
- -
- -
-201.49
- -
-35.44
-18.55
-21.35
-2.82
4.21
4.45
-3.35
6.62
6.31
Depreciation Expense
- -
- -
- -
- -
- -
- -
2
5
39
55
61
72
94
73
Net Income, GAAP
- -
- -
- -
-1
-6
-2
-8
-4
-44
1
- -
33
-7
23
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
14.67
- -
15.94
25.84
Profit Margin (%)
- -
- -
- -
-205.68
- -
-38.26
-23.83
-7.41
-14.61
0.24
0.01
3.55
-0.53
2.04
Working Capital
1
1
- -
- -
- -
- -
10
80
5
42
60
-36
12
-79
LT Debt
- -
- -
- -
- -
- -
- -
18
20
345
343
402
397
488
550
Total Equity
1
1
- -
- -
-1
- -
32
218
708
815
846
930
1,039
1,047
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.41
- -
5.21
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
2.03
-0.5
Return on Common Equity (%)
-38.72
-7.79
-39.47
-169.76
- -
- -
-55.3
-3.11
-11.34
0.23
0.01
4.52
-0.97
3.04

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
113
123
LT Borrowings
- -
421
483
LT Finance Leases
- -
67
67
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
254
256
Market Capitalization
1,290
1,010
961

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
370
379
Cash, Cash Equivalents & STI
- -
134
134
Accounts Receivable, Net
- -
171
181
Inventories
- -
2
2
Total Current Liabilities
- -
357
458
Payables & Accruals
- -
154
103
ST Debt
- -
113
123
Deferred Revenue
- -
49
33

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
52.96%
11.8%
Free Cash Flow
-79.85%
-354.62%
-1,502.42%
Net Income, GAAP
4,172.07%
8,086.81%
-122.57%
Sales/Revenue/Turnover
- -
139.43%
52.25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
223
227
234
193
920
2025
294
357
- -
385
1,400
2026
368
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.42
-0.39
- -
0.13
2025
-0.19
0.05
- -
- -
-0.03
2026
-0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Hamed Shahbazi
Full Time Employees
1,507
Sector
Healthcare
Industry
Medical - Care Facilities
Address
375 Water Street Vancouver BC Canada V6B 5C6
IPO Date
Feb 20, 2018
Business
WELL Health Technologies Corp. (TSX: WELL) operates as a practitioner-focused digital healthcare company, owning and operating the largest network of outpatient clinics in Canada focused on primary, allied, diagnostic, specialized, and preventative care services; providing omni-channel patient services in the United States including national telehealth, brick-and-mortar clinics, and anesthesia services across 19 states; and offering a comprehensive practitioner enablement platform with electronic medical records (EMR) systems such as OSCAR, Juno, Profile (Intrahealth), and Cerebrum (AwareMD); telehealth platforms; practice management software; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions; cybersecurity protection and patient data privacy tools; ePharma; digital booking; e-Referral; and e-Rx services. The company serves medical clinics, healthcare practitioners, and public sector healthcare systems in Canada, the United States, and internationally, targeting markets such as medical recruitment and staffing, anesthesia, gastrointestinal health, women’s health, primary care, and behavioural health. Founded in 2010 and headquartered in Vancouver, British Columbia, Canada, WELL Health Technologies continues to expand through strategic acquisitions and partnerships. Recent developments include the addition of $100 million in annualized revenue from seven acquisitions since December 2024, paid in cash; launches under the WELLSTAR division for advanced digital solutions; the acquisition of Harmony to enhance anesthesia staffing via CRH Medical; two clinic acquisitions in British Columbia in July 2025 adding over $12 million in annual revenue; and a 50/50 clinical research joint venture with HEALWELL AI established in November 2025 incorporating Bio Pharma Services.

Company News

APIChat
  • WELL Health Improves Guidance Based on WELL Canada Achieving $100 Million in Annualized Adjusted EBITDA Run-Rate Ahead of Schedule

  • WELL Health Announces Appointment of Healthcare Executive Derek Clark as Chief Operating Officer

  • WELL Health Announces Approval of Normal Course Issuer Bid

  • WELL Health Technologies Corp. (WELL:CA) Q1 2026 Earnings Call Transcript

  • WELL Health Delivers Record Q1-2026 with Canadian Clinics Run Rate Exceeding $500M and Revenue Up 25% to $368M

  • WELL Health to Announce First Quarter 2026 Financial Results on May 7, 2026

  • WELL Health Reports Record Canadian Patient Visits and Primary Care Margin Expansion in Q1-2026

  • WELL Subsidiary CYBERWELL Launches CYDEcore Fusion Platform and Provides Strategic Business Update to Address Escalating Cybersecurity Threats

  • WELL Health and WELLSTAR to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference

  • WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

  • WELL Health Supports Ontario's Commitment to a Provincewide Primary Care Medical Record System

  • WELL Health Technologies Corp. (WELL:CA) Q4 2025 Earnings Call Transcript

  • WELL Health Reports Record FY2025 Results; Canadian Patient Services Adjusted EBITDA Up 43% with Record Free Cash Flow

  • WELL Health Subsidiary WELLSTAR Expands National Billing Platform with Two Strategic Acquisitions, Now Serving Six Provinces

  • WELL Health to Report Fourth Quarter and Year End 2025 Financial Results on March 19, 2026

  • WELL Health Reports Record Canadian Patient Visits and Industry Leading Patient Satisfaction Metrics in 2025

  • WELL Health and HEALWELL AI Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

  • HEALWELL AI and WELL Health Launch WELLTRUST to Empower Patients and Accelerate AI Powered Ethical Patient Identification for Clinical Research

  • WELL Health Provides Corporate Update on Capital Allocation Program Including Expanded Credit Facility and the Strategic Acquisition of a Leading E-Consult Platform

  • WELL Health Releases CEO Letter to Shareholders